Candida nivariensis as an etiologic agent of vulvovaginal candidiasis in a tertiary care hospital of New Delhi, India

Diagnostic Microbiology and Infectious Disease

Volumn 76, Issue 1, 2013, Pages 46-50

  Sharma, Cheshta ^a   Wankhede, Sandeep ^a   Muralidhar, Sumathi ^b   Prakash, Anupam ^a   Singh, Pradeep K ^a   Kathuria, Shallu ^a   Kumar, Deepa Anil ^b   Khan, Nilofar ^b   Randhawa, Harbans S ^a   Meis, Jacques F ^c,d   Chowdhary, Anuradha ^a  

^a UNIVERSITY OF DELHI   (India)

^b SAFDARJUNG HOSPITAL   (India)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d CANISIUS WILHELMINA HOSPITAL   (Netherlands)

Author keywords

Antifungal susceptibility testing; Candida nivariensis; India; RPL31 PCR; Vulvovaginal candidiasis

Indexed keywords

AMPHOTERICIN B; ANIDULAFUNGIN; CASPOFUNGIN; ECHINOCANDIN; FLUCONAZOLE; FLUCYTOSINE; ISAVUCONAZOLE; ITRACONAZOLE; MICAFUNGIN; POSACONAZOLE; VORICONAZOLE;

ADULT; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; CANDIDA; CANDIDA NIVARIENSIS; CASE REPORT; CLINICAL FEATURE; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; FUNGAL COLONIZATION; FUNGUS ISOLATION; GENOTYPE; HUMAN; INDIA; MINIMUM INHIBITORY CONCENTRATION; NUCLEOTIDE SEQUENCE; PHENOTYPE; PHYLOGENY; PREVALENCE; PRIORITY JOURNAL; TERTIARY HEALTH CARE; VAGINA CANDIDIASIS;

ADULT; AMPHOTERICIN B; ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS, VULVOVAGINAL; DNA, FUNGAL; DRUG RESISTANCE, FUNGAL; ECHINOCANDINS; FEMALE; FLUCONAZOLE; GENOTYPE; HUMANS; INDIA; ITRACONAZOLE; MICROBIAL SENSITIVITY TESTS; NITRILES; PHENOTYPE; PHYLOGENY; POLYMERASE CHAIN REACTION; PYRIDINES; PYRIMIDINES; SEQUENCE ANALYSIS, DNA; TERTIARY CARE CENTERS; TRIAZOLES; YOUNG ADULT;

EID: 84876734548     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2013.02.023     Document Type: Article

References (24)

1. Alcoba-Flórez J., del Pilar Arévalo M., González-Paredes F.J., Cano J., Guarro J., Pérez-Roth E., et al. PCR protocol for specific identification of Candida nivariensis, a recently described pathogenic yeast. J Clin Microbiol 2005, 43:6194-6196.
2. Bishop J.A., Chase N., Magill S.S., Kurtzman C.P., Fiandaca M.J., Merz W.G. Candida bracarensis detected among isolates of Candida glabrata by peptide nucleic acid fluorescence in situ hybridization: susceptibility data and documentation of presumed infection. J Clin Microbiol 2008, 46:443-446.
3. Borman A.M., Petch R., Linton C.J., Palmer M.D., Bridge P.D., Johnson E.M. Candida nivariensis, an emerging pathogenic fungus with multidrug resistance to antifungal agents. J Clin Microbiol 2008, 46:933-938.
4. Chowdhary A., Randhawa H.S., Khan Z.U., Ahmad S., Juneja S., Sharma B., et al. First isolations in India of Candida nivariensis, a globally emerging opportunistic pathogen. Med Mycol 2010, 48:416-420.
5. Clinical and laboratory Standards Instiute (CLSI) Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard-third edition, M27-A3 2008, CLSI, Wayne, PA.
6. Correia A., Sampaio P., James S., Pais C. Candida bracarensis sp. nov., a novel anamorphic yeast species phenotypically similar to Candida glabrata. Int J Syst Evol Microbiol 2006, 56:313-317.
7. Cuenca-Estrella M., Gomez-Lopez A., Isla G., Rodriguez D., Almirante B., Pahissa A., et al. Prevalence of Candida bracarensis and Candida nivariensis in a Spanish collection of yeasts: comparison of results from a reference centre and from a population-based surveillance study of candidemia. Med Mycol 2011, 49:525-529.
8. Enache-Angoulvant A., Guitard J., Grenouillet F., Martin T., Durrens P., Fairhead C., et al. Rapid discrimination between Candida glabrata, Candida nivariensis, and Candida bracarensis by use of a singleplex PCR. J Clin Microbiol 2011, 49:3375-3379.
9. Esposto M.C., Prigitano A., Romeo O., Criseo G., Trovato L., Tullio V., et al. Looking for Candida nivariensis and C. bracarensis among a large Italian collection of C. glabrata isolates: results of the FIMUA working group. Mycoses 2012, 10.1111/myc.12026.
10. Fujita S., Senda Y., Okusi T., Ota Y., Takada H., Yamada K., et al. Catheter-related fungemia due to fluconazole-resistant Candida nivariensis. J Clin Microbiol 2007, 45:3459-3461.
11. Hettiarachchi N., Ashbee H.R., Wilson J.D. Prevalence and management of non-albicans vaginal candidiasis. Sex Transm Infect 2010, 86:99-100.
12. Kennedy M.A., Sobel J.D. Vulvovaginal candidiasis caused by non-albicans Candida species: new insights. Curr Infect Dis Rep 2010, 12:465-470.
13. Kurtzman C.P., Robnett C.J. Identification of clinically important ascomycetous yeasts based on nucleotide divergence in the 5' end of the large-subunit (26S) ribosomal DNA gene. J Clin Microbiol 1997, 35:1216-1223.
14. Lockhart S.R., Messer S.A., Gherna M., Bishop J.A., Merz W.G., Pfaller M.A., et al. Identification of Candida nivariensis and Candida bracarensis in a large global collection of Candida glabrata isolates: comparison to the literature. J Clin Microbiol 2009, 47:1216-1217.
15. López-Soria L.M., Bereciartua E., Santamaría M., Soria L.M., Hernández-Almaraz J.L., Mularoni A., et al. First case report of catheter-related fungemia by Candida nivariensis in the Iberian Peninsula. Rev Iberoam Micol 2012, [pii: S1130-1406(12)00086-1]. 10.1016/j.riam.2012.09.001.
16. Maganti H., Yamamura D., Xu J. Prevalent nosocomial clusters among causative agents for candidemia in Hamilton, Canada. Med Mycol 2011, 49:530-538.
17. Mirhendi H., Bruun B., Schønheyder H.C., Christensen J.J., Fuursted K., Gahrn-Hansen B., et al. Differentiation of Candida glabrata, C. nivariensis and C. bracarensis based on fragment length polymorphism of ITS1 and ITS2 and restriction fragment length polymorphism of ITS and D1/D2 regions in rDNA. Eur J Clin Microbiol Infect Dis 2011, 30:1409-1416.
18. Mohanty S., Xess I., Hasan F., Kapil A., Mittal S., Tolosa J.E. Prevalence and susceptibility to fluconazole of Candida species causing vulvovaginitis. Indian J Med Res 2007, 126:216-219.
19. Parmeland L., Gazon M., Guerin C., Argaud L., Lehot J.J., Bastien O., et al. Candida albicans and non-Candida albicans fungemia in an institutional hospital during a decade. Med Mycol 2013, 51:33-37.
20. Sobel J.D. Vulvovaginal candidosis. Lancet 2007, 369:1961-1971.
21. Tamura K., Peterson D., Peterson N., Stecher G., Nei M., Kumar S. MEGA5: Molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 2011, 28:2731-2739.
22. Wahyuningsih R., SahBandar I.N., Theelen B., Hagen F., Poot G., Meis J.F., et al. Candida nivariensis isolated from an Indonesian human immunodeficiency virus-infected patient suffering from oropharyngeal candidiasis. J Clin Microbiol 2008, 46:388-391.
23. White T.J., Bruns T., Lee S., Taylor J. Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics. PCR protocols: a guide to methods and applications 1990, 315-322. Academic Press, San Diego, CA. M.A. Innis, D.H. Gelfand, J.J. Sninsky, T.J. White (Eds.).
24. Xu J., Ramos A.R., Vilgalys R., Mitchell T.G. Clonal and spontaneous origins of fluconazole resistance in Candida albicans. J Clin Microbiol 2000, 38:1214-1220.